CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Alfasigma S.p.A.

For profitWebsite ↗

Also known as: ALFASIGMA | Alfasigma S.p.A. | Bama GeVe, S.L.U. | Clinedem

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 31, 2025

Timeline

2000s

Jul 24, 2002
tegaserod— Marketing Organization
Jul 24, 2002
tegaserod— NDA Secondary Org

2010s

Jun 1, 2015
Alfasigma S.p.A.— Founded

2020s

Sep 26, 2023
Intercept Pharmaceuticals— Acquired

Drugs by trial phase (11 distinct, 34 trials)

Phase 4 (3 own, 1 via acquisition)

Phase 3 (2 own, 1 via acquisition)

Phase 2 (0 own, 4 via acquisition)

Indications

Studied for

Marketed drugs (1)

tegaserod

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Intercept Pharmaceuticals

Recent trials (17)

NCT06865417Lead sponsorPhase 3May 31, 2025
NCT06222034Lead sponsorPhase 1May 13, 2024
NCT06222034OfficialPhase 1May 13, 2024
NCT06285539CollaboratorPhase 2Mar 12, 2024
NCT05371925CollaboratorPhase 3Jul 26, 2022
NCT05150587Lead sponsorPhase 2Oct 5, 2021
NCT04709770CollaboratorPhase 4Feb 1, 2021
NCT04483830Lead sponsorPhase 2/Phase 3Jun 5, 2020
NCT04483830CollaboratorPhase 2/Phase 3Jun 5, 2020
NCT04483830Reponsible party - principal investigatorPhase 2/Phase 3Jun 5, 2020
NCT04483830Overall official - principal investigatorPhase 2/Phase 3Jun 5, 2020
NCT03864978Lead sponsorPhase 2Jun 22, 2018
NCT03469050Study directorPhase 2/Phase 3May 31, 2018
NCT03469050Lead sponsorPhase 2/Phase 3May 31, 2018
NCT03537157Study directorPhase 2Nov 16, 2017

Details

Founded: MIlan, IT Jun 1, 2015
Last known activity: May 31, 2025